NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (Nasdaq: BLDE, “Blade” or the “Company”), a technology-powered air mobility platform, today announced that Mat Schneider, Vice President Investor Relations and Strategic Finance, will present at the 2025 J.P. Morgan Annual Global Technology, Media, and Communications Conference on Wednesday, May 14, 2025 at 3:40pm ET. A webcast of the event will be available at the link here. A replay will be available shortly after the conclusion of the pr ...

Financial Performance - Total revenue increased by $2.8 million or 5.4%, from $51.5 million in Q1 2024 to $54.3 million in Q1 2025[148]. - For the three months ended March 31, 2025, total revenue increased by 5.4% to $54.3 million from $51.5 million in the same period of 2024[162]. - Passenger segment revenue rose by $2.9 million, or 18.5%, from $15.5 million in 2024 to $18.4 million in 2025[164]. - Medical segment revenue decreased by $0.1 million, or 0.2%, from $36.0 million in 2024 to $35.9 million in 2025[167]. - Adjusted EBITDA improved by $2.3 million, from $(3.5) million in Q1 2024 to $(1.2) million in Q1 2025, primarily due to a $2.7 million improvement in the Passenger segment[171]. - Gross profit increased by $2.2 million, or 38.3%, from $5.9 million in Q1 2024 to $8.1 million in Q1 2025[172]. - Flight profit increased by $1.8 million, or 18.1%, from $10.1 million in Q1 2024 to $12.0 million in Q1 2025[172]. - Gross margin improved from 11.4% in Q1 2024 to 14.9% in Q1 2025[173]. - Flight margin increased from 19.7% in Q1 2024 to 22.1% in Q1 2025[173]. - The company had a net loss of $3.5 million for the three months ended March 31, 2025, an improvement from a net loss of $4.2 million in the same period of 2024[170]. Operational Highlights - Blade reported a total of 13,884 seats flown in all passenger flights for the three months ended March 31, 2025, compared to 13,286 seats in the same period of 2024, representing a growth of approximately 4.5%[116]. - The company discontinued operations in Canada on August 31, 2024, which previously accounted for 14,120 seats flown in the three months ended March 31, 2024[117]. - The company acquired ten fixed-wing aircraft dedicated to the Medical segment over the course of 2024, aiming to improve economies of scale and service reliability[120]. - Blade's proprietary technology stack enables real-time tracking of organ transports and passenger flights, enhancing operational efficiency and scalability[122]. - The MediMobility Organ Transport product line serves transplant centers and hospitals, with transportation requests typically made only hours before departure, emphasizing the need for reliability[126]. - Blade's growth strategy includes expanding its by-the-seat product offerings, which are crucial for increasing passenger revenue despite variability in pricing[115]. - The company anticipates leveraging the lower operating costs of Electric Vertical Aircraft (EVA) to reduce consumer prices and expand into new markets[123]. - Blade's ability to attract and retain fliers is critical, as competition from various transportation options necessitates effective marketing and service offerings[125]. - The organ transportation market is highly competitive, with Blade facing challenges from manufacturers of organ preservation equipment that also provide transportation services[127]. Revenue Breakdown - Short Distance revenue decreased by $0.5 million or (5.4)% from $9.8 million in Q1 2024 to $9.3 million in Q1 2025, primarily due to the termination of Canada routes[149]. - Jet and Other revenue increased by $3.4 million or 59.9%, from $5.7 million in Q1 2024 to $9.1 million in Q1 2025, driven by growth in jet charters[150]. - MediMobility Organ Transport revenue decreased by $(0.1) million or (0.2)% from $36.0 million in Q1 2024 to $35.9 million in Q1 2025 due to lower air flight hours[151]. Cost and Expenses - Cost of revenue increased by $1.0 million or 2.3%, from $41.4 million in Q1 2024 to $42.3 million in Q1 2025, with a decrease in cost of revenue as a percentage of revenue from 80% to 78%[152][153]. - Software development costs increased by $0.1 million or 21.2%, from $0.7 million in Q1 2024 to $0.8 million in Q1 2025[155]. - General and administrative expenses increased by $0.1 million or 0.6%, from $17.2 million in Q1 2024 to $17.3 million in Q1 2025[156]. - Selling and marketing expenses decreased by $(0.7) million or (32.6)%, from $2.1 million in Q1 2024 to $1.4 million in Q1 2025[158]. - Total other non-operating income decreased by $(1.5) million or (26.6)%, from $5.5 million in Q1 2024 to $4.1 million in Q1 2025[159]. Cash Flow and Liquidity - As of March 31, 2025, total liquidity was $120.0 million, consisting of cash and cash equivalents of $34.8 million and short-term investments of $85.2 million[186]. - For the three months ended March 31, 2025, net cash used in operating activities was $0.2 million, compared to $15.6 million for the same period in 2024[195][196]. - Net cash provided by investing activities for the three months ended March 31, 2025, was $20.4 million, driven by $107.8 million from maturities of held-to-maturity investments[197]. - The company has a stock repurchase program authorized for up to $20.0 million, with approximately $19.8 million remaining as of March 31, 2025[191]. - For the three months ended March 31, 2025, net cash used in financing activities was $4.2 million, primarily due to payroll tax payments on behalf of employees[199]. - The cash increase for the three months ended March 31, 2025, was $16.0 million, compared to an increase of $9.0 million for the same period in 2024[194]. - The company believes no additional capital will be needed to execute its current business plan over the next 12 months[192]. - The company’s longer-term liquidity requirements will depend on factors including market expansion pace and customer retention[192]. - As of March 31, 2025, the company has commitments to purchase flights with minimum guarantees of $4.9 million and $6.1 million for the years ending December 31, 2025 and 2026, respectively[189]. - The company has operating lease obligations with expected annual minimum payments of $1.6 million and $2.1 million for the years ending December 31, 2025 and 2026, respectively[189]. - The company entered into a technology service agreement for cloud computing services, committing to spend $0.6 million and $1.6 million for the years ending December 31, 2025 and 2026, respectively[190].

Core Insights - Blade Air Mobility, Inc. (BLDE) reported a quarterly loss of $0.04 per share, outperforming the Zacks Consensus Estimate of a loss of $0.11, and showing improvement from a loss of $0.06 per share a year ago [1] - The company achieved revenues of $54.31 million for the quarter ended March 2025, exceeding the Zacks Consensus Estimate by 9.55% and up from $51.51 million year-over-year [2] - Blade Air Mobility's shares have declined approximately 31.3% year-to-date, contrasting with the S&P 500's decline of 3.8% [3] Financial Performance - Over the last four quarters, Blade Air Mobility has surpassed consensus EPS estimates two times and topped consensus revenue estimates four times [2] - The current consensus EPS estimate for the upcoming quarter is -$0.04 on revenues of $65.57 million, and for the current fiscal year, it is -$0.17 on revenues of $256.96 million [7] Market Outlook - The earnings outlook for Blade Air Mobility is mixed, with a current Zacks Rank of 3 (Hold), indicating expected performance in line with the market [6] - The Technology Services industry, to which Blade Air Mobility belongs, is currently ranked in the top 27% of over 250 Zacks industries, suggesting a favorable industry outlook [8]

Blade Air Mobility (BLDE) Q1 2025 Earnings Call May 12, 2025 08:00 AM ET Speaker0 Good morning, ladies and gentlemen, and welcome to the Blade Air Mobility First Quarter twenty twenty five Earnings Release Conference Call. At this time, all participants are in a listen only mode. Later, we will conduct a question and answer session and instructions will follow at that time. As a reminder, this call is being recorded. I would now like to turn the call over to Matt Snyder, Vice President of Investor Relations ...

Investor Presentation May 2025 FORWARD LOOKING STATEMENTS This investor presentation contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts and may be identified by the use of words such as "will", "anticipate", "believe", "could", "continue", "expect", "estimate", "may", "plan", "outlook", "future", "target", and "project" and other simil ...

Exhibit 99.1 May 12, 2025 Blade Air Mobility Announces First Quarter 2025 Results NEW YORK — (May 12, 2025) — Blade Air Mobility, Inc. (Nasdaq: BLDE, "Blade" or the "Company"), today announced financial results for the first quarter ended March 31, 2025. | | (in thousands except percentages, unaudited) | | | | | | --- | --- | --- | --- | --- | --- | | | | | Three Months Ended March 31, | | | | | | 2025 | | 2024 | % Change | | Revenue | $ | 54,306 | $ | 51,514 | 5.4 % | | Cost of revenue | $ | 42,328 | $ | 4 ...

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (Nasdaq: BLDE, “Blade” or the “Company”), will release financial results for the first quarter ended March 31, 2025 on Monday, May 12, 2025 before the market opens. The company will hold a conference call the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Rob Wiesenthal, Blade’s Chief Executive Officer, and Will Heyburn, Blade’s Chief Financial Officer, and will include a question-and-answer session fo ...

Market Overview - The stock market is showing positive momentum as April closes, driven by hopes of easing trade tensions between China and the U.S. [1] - May presents a fresh opportunity for investors, particularly in penny stocks, as optimism around trade tariff resolutions builds [2][6] Company Analysis: Compass Therapeutics (NASDAQ: CMPX) - Compass Therapeutics has demonstrated strong stock performance in 2025, with a year-to-date increase of over 38%, currently trading at $1.94 [3][5] - The company is advancing its clinical pipeline, particularly with CTX-10726, a PD-1 x VEGF-A bispecific antibody, and plans to submit an IND by the end of 2025 [5][7] - Analysts predict a significant upside for CMPX, with a consensus "Buy" rating and an average price target of $12, indicating a potential increase of 527% over the next year [7] Company Analysis: Blade Air Mobility (NASDAQ: BLDE) - Blade Air Mobility operates a technology-enabled air transport platform, focusing on medical and passenger transportation, with expected double-digit growth in its medical business in 2025 [8] - The company has strengthened its financial position, achieving positive cash flow and maintaining a debt-free balance sheet with $136 million in cash, allowing for fleet growth and potential share buybacks [9] - Despite a recent rally of over 4% to $2.71, BLDE is down over 36% year-to-date, but analysts remain optimistic, forecasting a 117% upside with an average price target of $5.83 [9][11]

Group 1 - Blade Air Mobility's business is progressing positively, but it has not yet attracted significant investor attention [1] - The company's Q4 results showed weaknesses, particularly in guidance amid a challenging demand environment [1] - Narweena, an asset manager, focuses on identifying market dislocations and believes in achieving excess risk-adjusted returns through secular growth opportunities [1] Group 2 - Narweena's research emphasizes company and industry fundamentals to uncover unique insights, targeting deeply undervalued stocks [1] - The firm has a high risk appetite and a long-term investment horizon, favoring smaller cap stocks and markets with less obvious competitive advantages [1] - The aging population and low growth rates are expected to create new investment opportunities, while many industries may face stagnation or decline [1] Group 3 - The economic landscape is shifting towards asset-light businesses, reducing the need for infrastructure investments over time [1] - A large pool of capital is pursuing a limited set of investment opportunities, leading to rising asset prices and compressed risk premia [1] - Richard Durant, the leader of Narweena, has a strong educational background in engineering, finance, and an MBA, along with passing the CFA exams [1]

Financial Data and Key Metrics Changes - Blade Air Mobility achieved its first full year of adjusted EBITDA profitability with a $17.8 million year-over-year improvement in adjusted EBITDA for 2024 [8] - Revenue, excluding Canada, increased by 22.1% in Q4 2024 compared to the prior year, while Q4 flight profit rose by 40% year-over-year [9][10] - The company reported $127 million in cash and short-term investments at the end of 2024, with no debt [20][29] Business Line Data and Key Metrics Changes - Passenger segment adjusted EBITDA margin expanded by over 16 percentage points year-over-year, approaching break-even, driven by a 630 basis point improvement in flight margin and an 18% reduction in adjusted SG&A [23] - Medical revenue rose 13.7% year-over-year to $36.4 million, with adjusted EBITDA margin improving by over 700 basis points to 15.1% in Q4 2024 [24][26] - The passenger segment achieved $3.6 million of adjusted EBITDA for the full year 2024, an increase of $8.6 million versus the prior year [11] Market Data and Key Metrics Changes - The company noted a 2% sequential decline in heart, liver, and lung transplant volumes in Q4 2024 compared to Q3 2024, which was less than anticipated [25] - Early results from European restructuring showed strong year-over-year revenue growth and profitability improvement during the winter ski season [14] Company Strategy and Development Direction - Blade is focused on maximizing growth in Urban Air Mobility, particularly through its New York City airport transfer service, which saw high teens year-over-year revenue expansion in Q4 [10] - The company is transitioning to electric vertical aircraft (eVTOL) and is optimistic about the future growth opportunities in the organ transplant logistics market [10][41] - A strategic partnership with Skyports Infrastructure aims to enhance ground infrastructure for advanced air mobility, supporting the transition to eVTOL [14][16] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding the medical segment's growth, anticipating double-digit revenue growth in 2025 despite some uncertainty due to recent transplant volume trends [32][41] - The company expects to generate positive free cash flow before aircraft acquisitions, although cash flow will be impacted by elevated maintenance spending on owned aircraft [40] Other Important Information - Blade introduced a new mobile app to enhance user experience, offering features like easy flight booking and trip management [16] - The company is preparing for the launch of two new transplant centers in April, which will contribute to revenue growth [18] Q&A Session Summary Question: What catalysts will drive growth in the two businesses? - Management highlighted continued savings in SG&A and the onboarding of new customers in the medical segment as key growth drivers [50][52] Question: When can eVTOLs be expected? - Management anticipates eVTOLs may be operational in the Middle East by early 2026 and in the US by late 2027 or early 2028 [56][57] Question: How is the European market performing? - Management reported significant cost reductions and positive revenue growth in Europe, particularly during the ski season [73][75] Question: What is the strategy regarding passenger margins? - The company is optimizing its schedule and pricing strategy to enhance profitability rather than simply increasing seat count [82][86] Question: How will maintenance impact the Medical segment? - Management indicated that elevated maintenance in the first half of 2025 is due to time-based requirements and will affect operating leverage [100][102]